Glaucoma is a leading cause of blindness worldwide. Although intraocular pressure is the main risk factor for glaucoma, several intraocular pressure independent factors have been associated with the risk of developing the disease and its progression. The diagnosis of glaucoma relies on clinical features of the optic nerve, visual field test, and optical coherence tomography. However, the multidisciplinary aspect of the disease suggests that other biomarkers may be useful for the diagnosis, thus underling the importance of novel imaging techniques supporting clinicians. This review analyzes the common pathogenic mechanisms between glaucoma and Alzheimer's disease and the possible novel approaches for diagnosis and follow up.

Martucci, A., Picchi, E., Di Giuliano, F., Pocobelli, G., Mancino, R., Toschi, N., et al. (2022). Imaging biomarkers for Alzheimer's disease and glaucoma: Current and future practices. CURRENT OPINION IN PHARMACOLOGY, 62, 137-144 [10.1016/j.coph.2021.12.003].

Imaging biomarkers for Alzheimer's disease and glaucoma: Current and future practices

Martucci A.;Picchi E.;Di Giuliano F.;Mancino R.;Toschi N.;Floris R.;Garaci F.;Nucci C.
2022-01-01

Abstract

Glaucoma is a leading cause of blindness worldwide. Although intraocular pressure is the main risk factor for glaucoma, several intraocular pressure independent factors have been associated with the risk of developing the disease and its progression. The diagnosis of glaucoma relies on clinical features of the optic nerve, visual field test, and optical coherence tomography. However, the multidisciplinary aspect of the disease suggests that other biomarkers may be useful for the diagnosis, thus underling the importance of novel imaging techniques supporting clinicians. This review analyzes the common pathogenic mechanisms between glaucoma and Alzheimer's disease and the possible novel approaches for diagnosis and follow up.
2022
Pubblicato
Rilevanza internazionale
Recensione
Esperti anonimi
Settore MED/30 - MALATTIE APPARATO VISIVO
English
Martucci, A., Picchi, E., Di Giuliano, F., Pocobelli, G., Mancino, R., Toschi, N., et al. (2022). Imaging biomarkers for Alzheimer's disease and glaucoma: Current and future practices. CURRENT OPINION IN PHARMACOLOGY, 62, 137-144 [10.1016/j.coph.2021.12.003].
Martucci, A; Picchi, E; Di Giuliano, F; Pocobelli, G; Mancino, R; Toschi, N; Russo, R; Floris, R; Garaci, F; Nucci, C
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
1-s2.0-S1471489221001818-main.pdf

solo utenti autorizzati

Tipologia: Versione Editoriale (PDF)
Licenza: Copyright dell'editore
Dimensione 822.06 kB
Formato Adobe PDF
822.06 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/315603
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 6
  • ???jsp.display-item.citation.isi??? 5
social impact